{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:51:43Z","timestamp":1789044703007,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.actbio.2025.01.016","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T18:01:34Z","timestamp":1736532094000},"page":"392-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Macrophage membrane-camouflaged pure-drug nanomedicine for synergistic chemo- and interstitial photodynamic therapy against glioblastoma"],"prefix":"10.1016","volume":"193","author":[{"given":"Wei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiran","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3709-072X","authenticated-orcid":false,"given":"Xiangdong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2025.01.016_bib0001","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-med-042420-102102","article-title":"New approaches to glioblastoma","volume":"73","author":"Khasraw","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.actbio.2025.01.016_bib0002","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2025.01.016_bib0003","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2021.01.012","article-title":"Frontiers in the treatment of glioblastoma: past, present and emerging","volume":"171","author":"Janjua","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.01.016_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202203958","article-title":"Brain co-delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy","volume":"34","author":"Zou","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2025.01.016_bib0005","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.2174\/0929867324666170516123206","article-title":"Glioblastoma multiforme, diagnosis and treatment; recent literature review","volume":"24","author":"Batash","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actbio.2025.01.016_bib0006","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature13339","article-title":"Double function at the blood-brain barrier","volume":"509","author":"Betsholtz","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2025.01.016_bib0007","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2025.01.016_bib0008","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1038\/s41598-024-59955-y","article-title":"Efficacy of interstitial photodynamic therapy using talaporfin sodium and a semiconductor laser for a mouse allograft glioma model","volume":"14","author":"Nagai","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2025.01.016_bib0009","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41416-018-0210-y","article-title":"Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer","volume":"119","author":"Shafirstein","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.actbio.2025.01.016_bib0010","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1088\/0031-9155\/53\/15\/007","article-title":"Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate","volume":"53","author":"Li","year":"2008","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.actbio.2025.01.016_bib0011","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1364\/BOE.9.000898","article-title":"Automatic interstitial photodynamic therapy planning via convex optimization","volume":"9","author":"Yassine","year":"2018","journal-title":"Biomed. Opt. Express"},{"key":"10.1016\/j.actbio.2025.01.016_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9020012","article-title":"Interstitial photodynamic therapy-a focused review","volume":"9","author":"Shafirstein","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2025.01.016_bib0013","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.26.7.070604","article-title":"Perspectives on interstitial photodynamic therapy for malignant tumors","volume":"26","author":"Komolibus","year":"2021","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.actbio.2025.01.016_bib0014","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1021\/acs.chemrev.1c00381","article-title":"Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy","volume":"121","author":"Pham","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.actbio.2025.01.016_bib0015","doi-asserted-by":"crossref","first-page":"eabm8011","DOI":"10.1126\/sciadv.abm8011","article-title":"Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy","volume":"8","author":"Zou","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2025.01.016_bib0016","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1021\/acsnano.3c11958","article-title":"Cathepsin B-responsive programmed brain targeted delivery system for chemo-immunotherapy combination therapy of glioblastoma","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.01.016_bib0017","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2024.02.020","article-title":"Lipid-mediated protein corona regulation with increased apolipoprotein A-I recruitment for glioma targeting","volume":"368","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2025.01.016_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2024.04.010","article-title":"Regulatory insights into nanomedicine and gene vaccine innovation: safety assessment, challenges, and regulatory perspectives","volume":"180","author":"Souto","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2025.01.016_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210157","article-title":"Recent applications of immunomodulatory biomaterials for disease immunotherapy","volume":"2","author":"Dai","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.actbio.2025.01.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210134","article-title":"Stimuli-responsive crosslinked nanomedicine for cancer treatment","volume":"2","author":"Xue","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.actbio.2025.01.016_bib0021","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.09.042","article-title":"Drug-drug conjugates self-assembled nanomedicines triggered photo-\/immuno- therapy for synergistic cancer treatments","volume":"363","author":"Qu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2025.01.016_bib0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.actbio.2023.04.026","article-title":"A supramolecular assembly strategy for hydrophilic drug delivery towards synergistic cancer treatment","volume":"164","author":"Qu","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2025.01.016_bib0023","article-title":"Small-molecule nanoprodrug with high drug loading and EGFR, PI3K\/AKT dual-inhibiting properties for bladder cancer treatment","volume":"3","author":"Li","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.actbio.2025.01.016_bib0024","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.7150\/thno.21225","article-title":"Focused ultrasound immunotherapy for central nervous system pathologies: challenges and opportunities","volume":"7","author":"Curley","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2025.01.016_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.10.011","article-title":"Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption","volume":"250","author":"Park","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2025.01.016_bib0026","article-title":"Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma","volume":"34","author":"Wu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2025.01.016_bib0027","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2018.07.055","article-title":"Q. He, pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma","volume":"124","author":"Li","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2025.01.016_bib0028","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1038\/s41467-022-34462-8","article-title":"Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2025.01.016_bib0029","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2025.01.016_bib0030","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2025.01.016_bib0031","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","article-title":"Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain","volume":"8","author":"Anraku","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2025.01.016_bib0032","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2023.06.023","article-title":"Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: insights and challenges","volume":"360","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2025.01.016_bib0033","article-title":"Camouflaging nanoparticles with brain metastatic tumor cell membranes: a new strategy to traverse blood-brain barrier for imaging and therapy of brain tumors","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2025.01.016_bib0034","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2025.01.016_bib0035","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2025.01.016_bib0036","doi-asserted-by":"crossref","first-page":"20377","DOI":"10.1021\/acsnano.1c08689","article-title":"Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy\/chemodynamic therapy of orthotopic glioma","volume":"15","author":"Xiao","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.01.016_bib0037","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.actbio.2025.01.016_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1083645","article-title":"The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma","volume":"9","author":"Allami","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.actbio.2025.01.016_bib0039","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","article-title":"Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity","volume":"22","author":"Yin","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2025.01.016_bib0040","doi-asserted-by":"crossref","first-page":"37081","DOI":"10.18632\/oncotarget.9464","article-title":"Exploiting macrophages as targeted carrier to guide nanoparticles into glioma","volume":"7","author":"Pang","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.actbio.2025.01.016_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.01.016_bib0042","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.01.016_bib0043","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ccr.2011.08.025","article-title":"Macrophage binding to receptor vcam-1 transmits survival signals in breast cancer cells that invade the lungs","volume":"20","author":"Chen","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.actbio.2025.01.016_bib0044","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2012.02.022","article-title":"Use of macrophages to deliver therapeutic and imaging contrast agents to tumors","volume":"33","author":"Choi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.01.016_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122745","article-title":"Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo-\/immuno-therapy for cancer treatments","volume":"312","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.01.016_bib0046","doi-asserted-by":"crossref","first-page":"13267","DOI":"10.1007\/s12274-023-5912-7","article-title":"Charge-reversible crosslinked nanoparticle for pro-apoptotic peptide delivery and synergistic photodynamic cancer therapy","volume":"16","author":"Qu","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.actbio.2025.01.016_bib0047","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/adma.201302365","article-title":"Spatiotemporal drug release visualized through a drug delivery system with tunable aggregation-induced emission","volume":"26","author":"Xue","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2025.01.016_bib0048","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1039\/C6SC01254J","article-title":"An arch-bridge-type fluorophore for bridging the gap between aggregation-caused quenching (ACQ) and aggregation-induced emission (AIE)","volume":"7","author":"Huang","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.actbio.2025.01.016_bib0049","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1021\/nn5065452","article-title":"Probe-inspired nano-prodrug with dual-color fluorogenic property reveals spatiotemporal drug release in living cells","volume":"9","author":"Xue","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.01.016_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.133848","article-title":"Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma","volume":"433","author":"Yin","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2025.01.016_bib0051","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302156","article-title":"Macrophage membrane-camouflaged aggregation-induced emission nanoparticles enhance photodynamic-immunotherapy to delay postoperative tumor recurrence","volume":"13","author":"Meng","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2025.01.016_bib0052","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41467-022-33889-3","article-title":"Systematic design of cell membrane coating to improve tumor targeting of nanoparticles","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2025.01.016_bib0053","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1038\/s41467-023-40579-1","article-title":"Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2025.01.016_bib0054","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.3390\/ijms222312654","article-title":"Blood-brain barrier in brain tumors: biology and clinical relevance","volume":"22","author":"Mo","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T03:09:01Z","timestamp":1740625741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":54,"alternative-id":["S1742706125000212"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.01.016","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage membrane-camouflaged pure-drug nanomedicine for synergistic chemo- and interstitial photodynamic therapy against glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}